← Leaderboards
Mark W Peczuh
Princeton University
$442,850
Attributed
$442,850
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225.7K · FY2019–20$250K$187.5K$125K$62.5K$0
'19
'20
Funding mix
By agency
NIH$442,850 · 2
By mechanism
R21$397,004 · 1
F32$45,846 · 1
Top collaborators
No co-investigators on record.
Most similar at Princeton University
Same institution · by research overlap
- Pankaj Mehta$3,809,494
- Ned S Wingreen$8,000,313
- Andrew A. Bridges$1,053,579
- Robert H. Austin$7,220,602
- Lynn W. Enquist$11,741,004
Others in their field
Top investigators on “Carbohydrates”
- Robert Sackstein · Brigham And Women'S Hospital$23,640,386
- Frank M Sacks · Brigham And Women'S Hospital$23,399,903
- James Michael Pierce · University Of Georgia (Uga)$19,433,081
- James H Prestegard · University Of Georgia (Uga)$19,206,129
- Geert-Jan Boons · University Of Georgia (Uga)$16,957,104
- Dennis L. Kasper · Harvard Medical School$15,637,040
Research focus
CarbohydratesEscherichia ColiAnti-Infective AgentsBacterial InfectionsBacterial PiliBaseBiochemicalComplexCytotoxicityCarbohydrate StructureCell CommunicationCell CommunityCellsChemical SynthesisCommunitiesBindingConformerC-TerminalBacterial AdhesinsDesignDrug EvaluationElderlyElementsAffinity
Grant awards (4)
Ring Expanded Glycomimetic FimH Antagonists as Lead Compounds for anti-UTI Therapies$171,345
R21 · FY2020 · AI · contact PI
Ring Expanded Glycomimetic FimH Antagonists as Lead Compounds for anti-UTI Therapies$225,659
R21 · FY2019 · AI · contact PI
TRISACCHARIDE MIMETIC OF THE BAK BH3 ALPHA-HELIX$14,930
F32 · FY2001 · GM
TRISACCHARIDE MIMETIC OF THE BAK BH3 ALPHA-HELIX$30,916
F32 · FY2000 · GM